Precisely Targeting Cardiac Remodeling Nanomachine for Restarting Healthy Heartbeat.

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Cardiovascular Research

Background:

• Atrial fibrillation (AF) is a prevalent arrhythmia impacting patient quality of life.
• Current AF treatments face significant challenges.
• The electrophysiology of AF is critically dependent on intracellular ion gradients.

Purpose of the Study:

• To develop a novel nanomachine for AF treatment.
• To investigate the therapeutic potential of Zn@Mg@MSNs@PEG nanomachines.
• To assess the nanomachine's ability to target AF-related cardiac remodeling.

Main Methods:

• Fabrication of Zn@Mg@MSNs@PEG nanospheres with acid-responsive properties.
• Demonstration of autonomous nanomachine mobility in acidic conditions without toxic fuels.
• Analysis of nanomachine-induced changes in intracellular ion concentrations (Ca2+, Na+, K+, Cl-).
• Evaluation of the nanomachine's effect on electrophysiology, oxidative stress, and inflammation.

Main Results:

• The nanomachines exhibit autonomous, fuel-free mobility in acidic environments.
• Zn@Mg@MSNs@PEG nanomachines effectively modulate intracellular ion ratios crucial for AF.
• Therapeutic effects include electrophysiology amelioration, inhibition of oxidative stress and inflammation.
• Targeted inhibition of cardiac remodeling associated with AF was observed.

Conclusions:

• Zn@Mg@MSNs@PEG nanomachines offer a promising, targeted therapeutic strategy for AF.
• The acid-activated nanomachine system effectively addresses both structural and electrical abnormalities in AF.
• This approach achieves therapeutic benefits without causing additional damage.